AIDS in the Intensive Care Unit

[1]  J. Lundgren,et al.  Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P carinii pneumonia , 1999, The Lancet.

[2]  S. Meshnick.  Drug-resistant Pneumocystis carinii , 1999, The Lancet.

[3]  J. Montaner,et al.  Focus on Pneumocystis carinii pneumonia AIDS in the intensive care unit , 1999 .

[4]  Joel Tsevat,et al.  The Will To Live among HIV-Infected Patients , 1999, Annals of Internal Medicine.

[5]  I. G. Fantus,et al.  New-onset diabetes mellitus associated with protease inhibitor therapy in an HIV-positive patient: case report and review. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[6]  J. Singer,et al.  Determinants of short- and long-term outcome in patients with respiratory failure caused by AIDS-related Pneumocystis carinii pneumonia. , 1999, Archives of internal medicine.

[7]  P. Klotman,et al.  HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. , 1999, Kidney international.

[8]  S. Raoof,et al.  Role of bronchoscopy in AIDS. , 1999, Clinics in chest medicine.

[9]  R. Shafer,et al.  Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  R. Hogg,et al.  Antiretroviral therapy: 'the state of the art'. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  C. Jaspers,et al.  Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy , 1999, The Lancet.

[12]  B. Yip,et al.  The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  K. Sepkowitz,et al.  Human immunodeficiency virus infection, Part I. , 1998, Disease-a-month : DM.

[14]  R. Klein,et al.  Overview of HIV and AIDS: biology and epidemiology of the virus. , 1998, Gastrointestinal endoscopy clinics of North America.

[15]  M. Lederman,et al.  Recovery of the immune system with antiretroviral therapy: the end of opportunism? , 1998, JAMA.

[16]  J. Singer,et al.  Validation of the modified multisystem organ failure score as a predictor of mortality in patients with AIDS-related Pneumocystis carinii pneumonia and respiratory failure. , 1998, Chest.

[17]  E. Langhoff,et al.  Immunopathogenesis of human immunodeficiency virus. , 1998, Seminars in nephrology.

[18]  D. Grana,et al.  Cardiac involvement in acquired immunodeficiency syndrome—a review to push action , 1998, Clinical cardiology.

[19]  S. Hammer,et al.  Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. , 1998, JAMA.

[20]  J. Beck.  Pleural disease in patients with acquired immune deficiency syndrome. , 1998, Clinics in chest medicine.

[21]  S. Meshnick,et al.  Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients , 1998, AIDS.

[22]  David A. Cooper,et al.  A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors , 1998, AIDS.

[23]  G. Satten,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.

[24]  R. Hogg,et al.  Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. , 1998, JAMA.

[25]  A. Anzueto,et al.  The relation of pneumothorax and other air leaks to mortality in the acute respiratory distress syndrome. , 1998, The New England journal of medicine.

[26]  L. Hudson.  Protective ventilation for patients with acute respiratory distress syndrome. , 1998, The New England journal of medicine.

[27]  B. Régnier,et al.  Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU. , 1998, Chest.

[28]  F. Diaz,et al.  Management of elevated intracranial pressure in patients with Cryptococcal meningitis. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[29]  G. Masarotto,et al.  Role of bronchoalveolar lavage in predicting survival of patients with human immunodeficiency virus infection. , 1997, American journal of respiratory and critical care medicine.

[30]  Lenzo Np,et al.  Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: a case report. , 1997 .

[31]  J. Shapiro,et al.  Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: report of two patients and review of the literature. , 1997, Critical care medicine.

[32]  M. Saag,et al.  Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. , 1997, The New England journal of medicine.

[33]  Roger Detels,et al.  Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.

[34]  J. Lundgren,et al.  Alveolar damage in AIDS-related Pneumocystis carinii pneumonia. , 1997, Chest.

[35]  M. Boldt,et al.  Utility of lactate dehydrogenase vs radiographic severity in the differential diagnosis of Pneumocystis carinii pneumonia. , 1997, Chest.

[36]  M. Miravitlles,et al.  Empiric treatments impair the diagnostic yield of BAL in HIV-positive patients. , 1997, Chest.

[37]  N. Graham.  Epidemiology of acquired immunodeficiency syndrome: advancing to an endemic era. , 1997, The American journal of medicine.

[38]  T. Coyle.  Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. , 1997, The Medical clinics of North America.

[39]  D. Chin,et al.  Mycobacterial complications of HIV infection. , 1996, Clinics in chest medicine.

[40]  G. Sarosi,et al.  Fungal pulmonary complications. , 1996, Clinics in chest medicine.

[41]  J. M. Wallace.  Viruses and other miscellaneous organisms. , 1996, Clinics in chest medicine.

[42]  G. Noskin,et al.  Bacterial pneumonia associated with HIV-1 infection. , 1996, Clinics in chest medicine.

[43]  M. Rosen.  Overview of pulmonary complications. , 1996, Clinics in chest medicine.

[44]  W. Hardy.  The human immunodeficiency virus. , 1996, The Medical clinics of North America.

[45]  A. Valleron,et al.  AIDS in a medical intensive care unit: immediate prognosis and long-term survival. , 1996, JAMA.

[46]  G. Meduri,et al.  Noninvasive positive-pressure ventilation in patients with acute respiratory failure. , 1996, Clinics in chest medicine.

[47]  J. Stringer,et al.  Source of Pneumocystis carinii in recurrent episodes of pneumonia in AIDS patients. , 1996, AIDS.

[48]  J. Stringer,et al.  Molecular biology and epidemiology of Pneumocystis carinii infection in AIDS. , 1996, AIDS.

[49]  R. Chaisson,et al.  Natural History of Opportunistic Disease in an HIV-Infected Urban Clinical Cohort , 1996, Annals of Internal Medicine.

[50]  E. Raps,et al.  Critical neurologic illness in the immunocompromised patient. , 1995, Neurologic clinics.

[51]  F. Hecht,et al.  Suspected Pneumocystis carinii pneumonia with a negative induced sputum examination. Is early bronchoscopy useful? , 1995, American journal of respiratory and critical care medicine.

[52]  D. Dieterich,et al.  Gastrointestinal emergencies in the patient with AIDS. , 1995, Critical care clinics.

[53]  H. Newton.  Common neurologic complications of HIV-1 infection and AIDS. , 1995, American family physician.

[54]  M. Chevallier,et al.  Fulminant hepatitis with severe lactate acidosis in HIV‐infected patients on didanosine therapy , 1994, Journal of internal medicine.

[55]  Arthur S Slutsky.  Mechanical Ventilation , 1993, Chest.

[56]  M. Denis,et al.  Mechanical ventilation for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Is the prognosis really improved? , 1993, Chest.

[57]  A. Fauci,et al.  The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.

[58]  R. Baughman,et al.  Increased Pneumocystis carinii recovery from the upper lobes in Pneumocystis pneumonia. The effect of aerosol pentamidine prophylaxis. , 1993, Chest.

[59]  G. Wormser,et al.  Trimethoprim‐sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial , 1992, AIDS.

[60]  D. Denning,et al.  Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. , 1991, The American journal of medicine.

[61]  K. K. Lai,et al.  Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI). , 1991, Annals of internal medicine.

[62]  D. Palmer,et al.  Human immunodeficiency virus. , 1990, Journal of the American Podiatric Medical Association.

[63]  J. Montaner,et al.  Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS) , 1990, Annals of internal medicine.

[64]  P. Meier,et al.  Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. , 1990, The New England journal of medicine.

[65]  D. Abrams,et al.  Clinical manifestations of HIV infection , 1989 .

[66]  A. Schaffner,et al.  In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism. , 1986, The Journal of clinical investigation.

[67]  G. Friedland,et al.  Acquired immunodeficiency syndrome. , 1983 .

[68]  Philip R. Cohen,et al.  Cutaneous manifestations of HIV Infection , 2002 .

[69]  N. Schluger.  Issues in the treatment of active tuberculosis in human immunodeficiency virus-infected patients. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[70]  D. Havlir,et al.  Tuberculosis in patients with human immunodeficiency virus infection. , 1999, The New England journal of medicine.

[71]  J. Ward,et al.  Declines in AIDS incidence and deaths in the USA: a signal change in the epidemic. , 1998, AIDS.

[72]  M. Paiva,et al.  Intrapulmonary gas mixing in panacinar- and centriacinar-induced emphysema in rats. , 1998, American journal of respiratory and critical care medicine.

[73]  C. Sabin,et al.  The incubation period of AIDS. , 1997, AIDS.

[74]  P. Kvale,et al.  Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group. , 1997, American journal of respiratory and critical care medicine.

[75]  J. Montaner,et al.  Adjunctive Corticosteroid Therapy Decreases Lung Permeability in Patients with AIDS-Related Pneumocystis carinii Pneumonia , 1995 .

[76]  S. Bozzette.  Corticosteroids and other adjunctive agents , 1994 .

[77]  P. Unger,et al.  Disseminated Pneumocystis carinii infection causing extrapulmonary organ failure: clinical, pathologic, and immunohistochemical analysis. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[78]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .